.png)
Sensible Medical
Wearable radar vest (ReDS) for non-invasive lung-fluid measurement
Latest event found: 24 Aug 2026 · about 2 months ago
Vitality Radar
Pillar Analysis
Strategic Assessment
Strategic Vector
Sensible Medical appears focused on scaling ReDS radar-based, non-invasive lung-fluid monitoring through international commercialization partnerships and continued financing. Public evidence supports a technically differentiated heart-failure monitoring position, but recent organizational and operating momentum is less clearly documented.
Efficiency Ratio
The company appears to convert a relatively small specialist workforce into meaningful medtech commercialization activity, although limited public revenue and customer data make resource-to-output efficiency difficult to verify.
Evidence Signals
Sensible Medical announced a partnership intended to expand access to ReDS technology across additional territories and support pulmonary-congestion assessment for heart-failure patients.
Sensible Medical announced a collaboration with Wellesta to commercialize ReDS Pro in Southeast Asia and India.
Sensible Medical reportedly secured a $10 million Series A financing to accelerate growth initiatives; investor identities and detailed transaction terms were not disclosed.
- About
- Israeli medical-device company (HQ Netanya, Israel; commercial offices in the US), founded in 2007 by Amir Ronen. Its ReDS / SensiVest system is a non-invasive, wearable radar vest that measures lung fluid in ~90 seconds for heart-failure management — technology directly adapted from the Israeli military's 'see-through-wall' radar used to locate people in rubble. FDA 510(k)-cleared (2015) and CE-marked, with the ReDS Pro system contracted onto the US Federal Supply Schedule; licensed to Bayer in Europe and distributed in the US via Medicure. A rare defense-to-medical spinout — the RF/radar lineage is a genuine defense-tech hook within C12.
- Tags
- #radar #lungfluid #heartfailure #reds #seethroughwall #wearable #fda #dualuse #defenseorigin